logo-loader

PreveCeutical Medical names former Johnson & Johnson executive as consultant as it enters commercialization phase

Last updated: 12:25 01 Oct 2020 EDT, First published: 12:19 01 Oct 2020 EDT

PreveCeutical Medical Inc. -
PreveCeutical CEO Van Deventer said the company was very excited and fortunate to have Dr. Shetty work with them

PreveCeutical Medical Inc (CSE:PREV) (OTCQB:PRVCF) (FRA:18H), the health sciences group, has named former executive at multinational giant Johnson & Johnson (NYSE:JNJ) Dr. Ajit Shetty as an advisor and consultant to the company.

"With the company actively working on development, clinical trials, and commercialization of its products, Dr. Shetty's guidance will be very critical in its success," said Stephen Van Deventer, PreveCeutical's chief executive in a brief statement.

READ: PreveCeutical pleased with rodent model of opioid substitute pain-reliever 

"We are very excited and fortunate to have Dr. Shetty work with us."

Illustrious Dr Shetty brings extensive pharmaceutical experience leading commercial and supply chain operations and was 36 years at Johnson & Johnson (J&J) in a wide range of global roles.

"From 2007 to 2012, he served as corporate vice president, enterprise supply chain reporting to the CEO and was responsible for the transformation and optimization of J&J's supply chain. In addition, from 2004 to 2012, he served as chairman of Janssen Pharmaceutic," noted Preveceutical.

He was elected "Manager of the Year 2004" by the magazine Trends, and Kanaal Z and was awarded the Right Honourable Sir and Title of Baron by King Albert II of Belgium in 2008 and the Life-Time Achievement Award by India in 2010.

Shares in Canada were unchanged at C$0.040.

Contact the author at giles@proactiveinvestors.com

PreveCeutical Medical announces completion on analgesic program is near

PreveCeutical Medical (CSE:PREV-OTCQB: PRVCF) CEO Stephen Van Deventer joined Steve Darling from Proactive Vancouver with news the company’s current stage of research for its disulfide linker technology will be completed soon. Van Deventer telling Proactive about the program and what the next...

on 23/7/20